The purpose of the company is to develop innovative therapeutics for the treatment of human diseases through protein, DNA and RNA engineering, as well as the development, ownership and exploitation of intellectual property rights in this field. The company may establish subsidiaries and branches in Switzerland and abroad. The company may conduct all business activities related to its purpose and suitable to support the company; in particular, the company may conduct financing transactions for itself or for third parties and grant guarantees or other securities. The company may participate in or merge with other companies of any kind. It may acquire, encumber and dispose of real estate and intellectual property rights in Switzerland and abroad. The company may provide securities and guarantees for its shareholders or other group companies and grant loans to its shareholders or other group companies.
Outbound Leads by COHAGA